GE HealthCare Technologies Financial Ratios
NASDAQ: GEHCHealth CareMedical ElectronicsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GE HealthCare Technologies ratio analysis
GE HealthCare Technologies earned a net margin of 10.1% in FY 2025, down from 10.1% a year earlier. Gross margin was 40.0% compared with a median of 40.7% over the prior 4 years. Return on equity reached 20.1%, meaning GE HealthCare Technologies generated 0.20 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 1.01 versus 1.24 the year before, and the current ratio was 1.37. At the end of FY 2025, GEHC traded at 18.2 times earnings; across the 4 fiscal years shown, its year-end P/E ranged from 13.8 to 25.5, with a median of 18.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
GE HealthCare Technologies financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 18.20 | 18.55 | 25.52 | 13.83 | — |
| Price / sales | 1.83 | 1.87 | 1.80 | 1.45 | — |
| Price / book | 3.64 | 4.35 | 4.93 | 2.83 | — |
| Gross margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating margin | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% |
| Net margin | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% |
| Free cash flow margin | 7.3% | 7.9% | 8.8% | 9.9% | 7.7% |
| Return on equity (ROE) | 20.1% | 23.6% | 22.0% | 20.5% | 13.5% |
| Return on assets (ROA) | 5.6% | 6.0% | 4.8% | 7.0% | — |
| Debt / equity | 1.01 | 1.24 | 1.46 | 0.88 | — |
| Current ratio | 1.37 | 1.04 | 1.05 | 1.16 | — |
| Revenue growth | 4.8% | 0.6% | 6.6% | 4.3% | — |
| EPS growth | 4.8% | 43.2% | -28.2% | -14.7% | — |